Xtl Biopharmaceuticals (XTLB) Other Non Operating Income (2013 - 2024)
Xtl Biopharmaceuticals (XTLB) posted Other Non Operating Income of $2000.0 for Q4 2024, down 84.62% sequentially from $13000.0 in Q3 2024, and down 81.82% YoY from $11000.0 in Q1 2024.
Xtl Biopharmaceuticals (XTLB) Other Non Operating Income (2013 - 2024) Analysis & Trends
Xtl Biopharmaceuticals has reported Other Non Operating Income for 11 years, with the latest figure at $2000.0 in Q4 2024.
- Quarterly Other Non Operating Income fell 81.82% year-over-year to $2000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $34000.0 (down 17.07% YoY) and the FY2025 annual result came in at $60000.0, up 76.47% from the prior year.
- Other Non Operating Income fell to $2000.0 in Q4 2024 per XTLB's latest filing, from $13000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $495000.0 in Q2 2022 and troughed at -$776000.0 in Q2 2021.
- A 5-year average of -$9437.5 and a median of $9500.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2021 and 2023: Other Non Operating Income sank 6069.23% in 2021, then soared 300.0% in 2023.
- Over 5 years, Other Non Operating Income stood at $29000.0 in 2020, then plunged by 2775.86% to -$776000.0 in 2021, then soared by 101.55% to $12000.0 in 2022, then fell by 8.33% to $11000.0 in 2023, then slumped by 81.82% to $2000.0 in 2024.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $2000.0, $13000.0, and $9000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xtl Biopharmaceuticals | 2.64 Bn | 2.64 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 495,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Jun 30, 2021 | -776,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | -9,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Sep 30, 2019 | 20,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Sep 30, 2018 | 131,000.00 |